Sigma-Aldrich Joins RNAi Consortium
The consortium involves scientific collaborations between principal investigators at seven research institutions: Massachusetts General Hospital, Harvard Medical School, Dana-Farber Cancer Institute, The Broad Institute, Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology and Academia Sinica. In addition to Sigma-Aldrich, TRC also includes corporate partners Bristol-Myers Squibb, Eli Lilly and Novartis.
"These 11 world-class entities will make common cause in a unique collaborative group to create a public good: a comprehensive set of reagents to be used in thousands of laboratories," said Dr. Eric S. Lander, Director of the Broad Institute and one of TRC's principal investigators. "In addition, the organizations will each benefit from sharing their expertise to advance the technology and to accelerate its systematic application in basic biomedical research and drug discovery."
RNAi is a natural cellular process that is involved in the regulation of gene expression. In recent years scientists have developed methods that allow RNAi to be exploited as a research tool to decipher the function of particular genes. The goal of the consortium is to create widely applicable RNAi research reagents that will enable biomedical researchers to discover the key genes underlying normal physiology as well as disease states. It is widely believed that RNAi will revolutionize the way in which life science research is conducted and is expected to have a major impact on the understanding of the genetic basis of diseases such as cancer, arthritis and Alzheimer's.
Topics
Organizations
Other news from the department science
These products might interest you
Gilson MyPIPETMAN Select and MyPIPETMAN Enterprise Pipettes by Gilson
Grab the Gilson pipettes with your name and favorite colors!
Customise Your Pipettes to Fit Your Research
Whatman™ folded filter papers by Cytiva
Whatman folded filter papers
Convenient folded formats speed up your sample preparation
Systec H-Series by Systec
Safe, reproducible and validatable sterilization of liquids, solids and waste
Autoclaves with 65-1580 liters usable space, flexibly expandable for various applications
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.